Antonio C Wolff

Professor

1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer

Yang, D. D., Buscariollo, D. L., Cronin, A. M., Weng, S., Hughes, M. E., Bleicher, R. J., Cohen, A. L., Javid, S. H., Edge, S. B., Moy, B., Niland, J. C., Wolff, A. C., Hassett, M. J. & Punglia, R. S., Aug 17 2020, In : Radiation oncology (London, England). 15, 1, p. 198 1 p.

Research output: Contribution to journalArticle

Open Access

Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?

Choi, Y., Smith, K. C., Shukla, A., Blackford, A. L., Wolff, A. C., Thorner, E., Peairs, K. S., El Ayass, W., Njoku, P., Papathakis, K., Riley, C. D., Zafman, N., Asrari, F., Camp, M., Wright, J. L., Mayonado, N. J., White, S. M. & Snyder, C. F., Jan 1 2020, In : Breast Cancer Research and Treatment. 179, 2, p. 415-424 10 p.

Research output: Contribution to journalArticle

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

the Translational Breast Cancer Research Consortium (TBCRC), Jun 1 2020, In : Breast Cancer Research and Treatment. 181, 3, p. 623-633 11 p.

Research output: Contribution to journalArticle

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

Fackler, M. J., Cho, S., Cope, L., Gabrielson, E., Visvanathan, K., Wilsbach, K., Meir-Levi, D., Lynch, C. F., Marks, J., Geradts, J., Regan, M. M., Viale, G., Wolff, A. C., Sukumar, S. & Umbricht, C. B., Dec 1 2020, In : npj Breast Cancer. 6, 1, 3.

Research output: Contribution to journalArticle

Open Access

Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update

Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L., Hayes, D. F., Lakhani, S. R., Chavez-MacGregor, M., Perlmutter, J., Perou, C. M., Regan, M. M., Rimm, D. L., Symmans, W. F., Torlakovic, E. E., Varella, L., Viale, G., Weisberg, T. F., McShane, L. M. & Wolff, A. C., Apr 20 2020, In : Journal of Clinical Oncology. 38, 12, p. 1346-1366 21 p.

Research output: Contribution to journalArticle

Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update

Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L., Hayes, D. F., Lakhani, S. R., Chavez-MacGregor, M., Perlmutter, J., Perou, C. M., Regan, M. M., Rimm, D. L., Symmans, W. F., Torlakovic, E. E., Varella, L., Viale, G., Weisberg, T. F., McShane, L. M. & Wolff, A. C., May 2020, In : Archives of Pathology and Laboratory Medicine. 144, 5, p. 545-563 19 p.

Research output: Contribution to journalArticle

Open Access

Evaluation of the predictive role of tumor immune infiltrate in patients with HER2-positive breast cancer treated with neoadjuvant anti-HER2 therapy without chemotherapy

de Angelis, C., Nagi, C., Hoyt, C. C., Liu, L., Roman, K., Wang, C., Zheng, Y., Veeraraghavan, J., Sethunath, V., Nuciforo, P., Wang, T., Tsimelzon, A., Mao, S., Hilsenbeck, S. G., Trivedi, M. V., Cataldo, M. L., Pavlick, A., Wolff, A. C., Weigelt, B., Reis-Filho, J. S. & 5 others, Prat, A., Gutierrez, C., Osborne, C. K., Rimawi, M. F. & Schiff, R., Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 738-745 8 p.

Research output: Contribution to journalArticle

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Prat, A., Pascual, T., De Angelis, C., Gutierrez, C., Llombart-Cussac, A., Wang, T., Cortés, J., Rexer, B., Paré, L., Forero, A., Wolff, A. C., Morales, S., Adamo, B., Brasó-Maristany, F., Vidal, M., Veeraraghavan, J., Krop, I., Galván, P., Pavlick, A. C., Bermejo, B. & 15 others, Izquierdo, M., Rodrik-Outmezguine, V., Reis-Filho, J. S., Hilsenbeck, S. G., Oliveira, M., DIeci, M. V., Griguolo, G., Fasani, R., Nuciforo, P., Parker, J. S., Conte, P., Schiff, R., Guarneri, V., Osborne, C. K. & Rimawi, M. F., Jan 1 2020, In : Journal of the National Cancer Institute. 112, 1, p. 46-54 9 p.

Research output: Contribution to journalArticle

Patient-reported outcomes in the Translational Breast Cancer Research Consortium

Bowen, D. J., Shinn, E. H., Gregrowski, S., Kimmick, G., Dominici, L. S., Frank, E. S., Smith, K. L., Rocque, G., Ruddy, K. J., Pollastro, T., Melisko, M., Ballinger, T. J., Fayanju, O. M. & Wolff, A. C., Mar 1 2020, In : Cancer. 126, 5, p. 922-930 9 p.

Research output: Contribution to journalComment/debate

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

Translational Breast Cancer Research Consortium (TBCRC), Apr 2020, In : Clinical Breast Cancer. 20, 2, p. 145-151.e2

Research output: Contribution to journalArticle

TBCRC023: A randomized phase II neoadjuvant trial of lapatinib plus trastuzumab without chemotherapy for 12 versus 24 weeks in patients with HER2-positive breast cancer

on behalf of the Translational Breast Cancer Research Consortium, Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 821-827 7 p.

Research output: Contribution to journalArticle

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Tung, N., Arun, B., Hacker, M. R., Hofstatter, E., Toppmeyer, D. L., Isakoff, S. J., Borges, V., Legare, R. D., Isaacs, C., Wolff, A. C., Marcom, P. K., Mayer, E. L., Lange, P. B., Goss, A. J., Jenkins, C., Krop, I. E., Winer, E. P., Schnitt, S. J. & Garber, J. E., May 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1539-1548 10 p.

Research output: Contribution to journalArticle

The Effects of a remote-based weight loss program on adipocytokines, metabolic markers, and telomere length in breast cancer survivors: The POWER-remote trial

Santa-Maria, C. A., Coughlin, J. W., Sharma, D., Armanios, M., Blackford, A. L., Schreyer, C., Dalcin, A., Carpenter, A., Jerome, G. J., Armstrong, D. K., Chaudhry, M., Cohen, G. I., Connolly, R. M., Fetting, J., Miller, R. S., Smith, K. L., Snyder, C., Wolfe, A., Wolff, A. C., Huang, C. Y. & 2 others, Appel, L. J. & Stearns, V., Jun 15 2020, In : Clinical Cancer Research. 26, 12, p. 3024-3034 11 p.

Research output: Contribution to journalArticle

2019

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

Veeraraghavan, J., De Angelis, C., Mao, R., Wang, T., Herrera, S., Pavlick, A. C., Contreras, A., Nuciforo, P., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Chang, J. C., Wolff, A. C., Krop, I. E., Fuqua, S. A. W., Prat, A., Hilsenbeck, S. G., Weigelt, B., Reis-Filho, J. S. & 4 others, Gutierrez, C., Osborne, C. K., Rimawi, M. F. & Schiff, R., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 927-933 7 p., mdz076.

Research output: Contribution to journalArticle

Open Access

Adjuvant Anti-HER2 Therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno-Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & De Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, djy094.

Research output: Contribution to journalArticle

A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB)

Mayer, I. A., Prat, A., Egle, D., Blau, S., Alejandro Perez Fidalgo, J., Gnant, M., Fasching, P. A., Colleoni, M., Wolff, A. C., Winer, E. P., Singer, C. F., Hurvitz, S., Estevez, L. G., Van Dam, P. A., Kummel, S., Mundhenke, C., Holmes, F., Babbar, N., Charbonnier, L., Diaz-Padilla, I. & 3 others, Vogl, F. D., Sellami, D. & Arteaga, C. L., 2019, In : Clinical Cancer Research. 25, 10, p. 2975-2987 13 p.

Research output: Contribution to journalArticle

Open Access

Breast cancer survivorship care beyond local and systemic therapy

Sheng, J. Y., Visvanathan, K., Thorner, E. & Wolff, A. C., Nov 2019, In : Breast. 48, p. S103-S109

Research output: Contribution to journalArticle

Open Access

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno-Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journalArticle

DNA methylation markers for breast cancer detection in the developing world

Downs, B. M., Mercado-Rodriguez, C., Cimino-Mathews, A., Chen, C., Yuan, J. P., Van Den Berg, E., Cope, L. M., Schmitt, F., Tse, G. M., Ali, S. Z., Meir-Levi, D., Sood, R., Li, J., Richardson, A. L., Mosunjac, M. B., Rizzo, M., Tulac, S., Kocmond, K. J., De Guzman, T., Lai, E. W. & 9 others, Rhees, B., Bates, M., Wolff, A. C., Gabrielson, E., Harvey, S. C., Umbricht, C. B., Visvanathan, K., Fackler, M. J. & Sukumar, S., Nov 1 2019, In : Clinical Cancer Research. 25, 21, p. 6357-6367 11 p.

Research output: Contribution to journalArticle

Examining Generalizability of Older Adults’ Preferences for Discussing Cessation of Screening Colonoscopies in Older Adults with Low Health Literacy

Schoenborn, N. L., Crossnohere, N. L., Janssen, E. M., Pollack, C. E., Boyd, C. M., Wolff, A. C., Xue, Q. L., Massare, J., Blinka, M. & Bridges, J. F. P., Nov 1 2019, In : Journal of general internal medicine. 34, 11, p. 2512-2519 8 p.

Research output: Contribution to journalArticle

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Hurria, A., Soto-Perez-de-Celis, E., Allred, J. B., Cohen, H. J., Arsenyan, A., Ballman, K., Le-Rademacher, J., Jatoi, A., Filo, J., Mandelblatt, J., Lafky, J. M., Kimmick, G., Klepin, H. D., Freedman, R. A., Burstein, H., Gralow, J., Wolff, A. C., Magrinat, G., Barginear, M. & Muss, H., May 2019, In : Journal of the American Geriatrics Society. 67, 5, p. 920-927 8 p.

Research output: Contribution to journalArticle

Implications of neoadjuvant therapy in human epidermal growth factor receptor 2–positive breast cancer

Wolff, A. C., Tung, N. M. & Carey, L. A., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2189-2193 5 p.

Research output: Contribution to journalReview article

In reply

(on behalf of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Guideline Expert Panel), Apr 2019, In : Archives of Pathology and Laboratory Medicine. 143, 4, p. 413-414 2 p.

Research output: Contribution to journalLetter

Open Access

Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

Bellon, J. R., Guo, H., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Wolff, A. C., Carey, L. A., Overmoyer, B. A., Partridge, A. H., Hudis, C. A., Krop, I., Burstein, H. J., Winer, E. P. & Tolaney, S. M., Jul 30 2019, In : Breast Cancer Research and Treatment. 176, 2, p. 303-310 8 p.

Research output: Contribution to journalArticle

Randomized trial of standard adjuvant chemotherapy regimens versus capecitabine in older women with early breast cancer: 10-year update of the CALGB 49907 trial

Muss, H. B., Polley, M. Y. C., Berry, D. A., Liu, H., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Kartcheske, P. A., Perez, E. A., Wolff, A. C., Gralow, J. R., Burstein, H. J., Mahmood, A. A., Sutton, L. M., Magrinat, G., Parker, B. A. & 8 others, Hart, R. D., Grenier, D., Hurria, A., Jatoi, A., Norton, L., Hudis, C. A., Winer, E. P. & Carey, L., Sep 10 2019, In : Journal of Clinical Oncology. 37, 26, p. 2338-2348 11 p.

Research output: Contribution to journalArticle

Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2–positive breast cancer

Tolaney, S. M., Guo, H., Pernas, S., Barry, W. T., Dillon, D. A., Ritterhouse, L., Schneider, B. P., Shen, F., Fuhrman, K., Baltay, M., Dang, C. T., Yardley, D. A., Moy, B., Kelly Marcom, P., Albain, K. S., Rugo, H. S., Ellis, M. J., Shapira, I., Wolff, A. C., Carey, L. A. & 6 others, Overmoyer, B., Partridge, A. H., Hudis, C. A., Krop, I. E., Burstein, H. J. & Winer, E. P., 2019, In : Journal of Clinical Oncology. 37, 22, p. 1868-1875 8 p.

Research output: Contribution to journalArticle

Sharing in care: engaging care partners in the care and communication of breast cancer patients

Wolff, J. L., Aufill, J., Echavarria, D., Heughan, J. A. A., Lee, K. T., Connolly, R. M., Fetting, J. H., Jelovac, D., Papathakis, K., Riley, C., Stearns, V., Thorner, E., Zafman, N., Levy, H. P., Dy, S. M. & Wolff, A. C., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 127-136 10 p.

Research output: Contribution to journalArticle

Survivorship care visits in a high-risk population of breast cancer survivors

Skuli, S. J., Sheng, J. Y., Bantug, E. T., Zafman, N., Riley, C., Ruck, J. M., Smith, K. C., Snyder, C. F., Smith, K. L., Stearns, V. & Wolff, A. C., Feb 15 2019, In : Breast Cancer Research and Treatment. 173, 3, p. 701-708 8 p.

Research output: Contribution to journalArticle

TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases

Freedman, R. A., Gelman, R. S., Anders, C. K., Melisko, M. E., Parsons, H. A., Cropp, A. M., Silvestri, K., Cotter, C. M., Componeschi, K. P., Marte, J. M., Connolly, R. M., Moy, B., Van Poznak, C. H., Blackwell, K. L., Puhalla, S. L., Jankowitz, R. C., Smith, K. L., Ibrahim, N., Moynihan, T. J., O'Sullivan, C. C. & 10 others, Nangia, J., Niravath, P., Tung, N., Pohlmann, P. R., Burns, R., Rimawi, M. F., Krop, I. E., Wolff, A. C., Winer, E. P. & Lin, N. U., 2019, In : Journal of Clinical Oncology. 37, 13, p. 1081-1089 9 p.

Research output: Contribution to journalArticle

Open Access

TBCRC026: Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer

Connolly, R. M., Leal, J. P., Solnes, L., Huang, C. Y., Carpenter, A., Gaffney, K., Abramson, V., Carey, L. A., Liu, M. C., Rimawi, M., Specht, J., Storniolo, A. M., Valero, V., Vaklavas, C., Krop, I. E., Winer, E. P., Camp, M., Miller, R. S., Wolff, A. C., Cimino-Mathews, A. & 3 others, Park, B. H., Wahl, R. L. & Stearns, V., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 714-722 9 p.

Research output: Contribution to journalArticle

Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx

Andre, F., Ismaila, N., Henry, N. L., Somerfield, M. R., Bast, R. C., Barlow, W., Collyar, D. E., Hammond, M. E., Kuderer, N. M., Liu, M. C., Van Poznak, C., Wolff, A. C. & Stearns, V., Aug 1 2019, In : Journal of Clinical Oncology. 37, 22, p. 1956-1964 9 p.

Research output: Contribution to journalReview article

2018

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C. A., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R. M., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G. L., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., Aug 1 2018, In : Breast Cancer Research and Treatment. 171, 1, p. 121-129 9 p.

Research output: Contribution to journalArticle

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Sparano, J., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W. & Miller, K. D., Dec 2018, In : JAMA Oncology. 4, 12, p. 1700-1706 7 p.

Research output: Contribution to journalArticle

First international TNBC conference meeting report

Rida, P., Ogden, A., Ellis, I. O., Varga, Z., Wolff, A. C., Traina, T. A., Hatzis, C., Palmer, J. R., Ambrosone, C. B., Lehmann, B. D., Nanda, R., Montgomery Rice, V., Brawley, O. W., Torres, M. A., Rakha, E. & Aneja, R., Jun 1 2018, In : Breast Cancer Research and Treatment. 169, 3, p. 407-412 6 p.

Research output: Contribution to journalReview article

HER2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline focused update summary

Wolff, A. C., Elizabeth Hale Hammond, M., Allison, K. H., Harvey, B. E., McShane, L. M. & Dowsett, M., Jul 1 2018, In : Journal of oncology practice. 14, 7, p. 437-441 5 p.

Research output: Contribution to journalArticle

Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/ college of American pathologists clinical practice guideline focused update

Wolff, A. C., Elizabeth Hale Hammond, M., Allison, K. H., Harvey, B. E., Mangu, P. B., Bartlett, J. M. S., Bilous, M., Ellis, I. O., Fitzgibbons, P., Hanna, W., Jenkins, R. B., Press, M. F., Spears, P. A., Vance, G. H., Viale, G., McShane, L. M. & Dowsett, M., Jul 10 2018, In : Journal of Clinical Oncology. 36, 20, p. 2105-2122 18 p.

Research output: Contribution to journalArticle

Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Wolff, A. C., McShane, L. M., Hammond, M. E. H., Allison, K. H., Fitzgibbons, P., Press, M. F., Harvey, B. E., Mangu, P. B., Bartlett, J. M. S., Hanna, W., Bilous, M., Ellis, I. O., Dowsett, M., Jenkins, R. B., Spears, P. A., Vance, G. H. & Viale, G., Nov 2018, In : Archives of Pathology and Laboratory Medicine. 142, 11, p. 1364-1382 19 p.

Research output: Contribution to journalReview article

Molecular determinants of post-mastectomy breast cancer recurrence

Keene, K. S., King, T., Hwang, E. S., Peng, B., McGuire, K. P., Tapia, C., Zhang, H., Bae, S., Nakhlis, F., Klauber-Demore, N., Meszoely, I., Sabel, M. S., Willey, S. C., Eterovic, A. K., Hudis, C., Wolff, A. C., De Los Santos, J., Thompson, A., Mills, G. B. & Meric-Bernstam, F., Dec 1 2018, In : npj Breast Cancer. 4, 1, 34.

Research output: Contribution to journalArticle

Older adults’ preferences for discussing long-term life expectancy: Results from a national survey

Schoenborn, N. L., Janssen, E. M., Boyd, C., Bridges, J. F. P., Wolff, A. C., Xue, Q. L. & Pollack, C. E., 2018, In : Annals of family medicine. 16, 6, p. 530-537 8 p.

Research output: Contribution to journalArticle

Preferred clinician communication about stopping cancer screening among older US adults: Results from a national survey

Schoenborn, N. L., Janssen, E., Boyd, C. M., Bridges, J., Wolff, A. C. & Pollack, C. E., Aug 1 2018, In : JAMA oncology. 4, 8, p. 1126-1128 3 p.

Research output: Contribution to journalLetter

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G., Jeter, S. C., Armstrong, D. K., Emens, L. A., Fetting, J. H., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

Kornblum, N., Zhao, F., Manola, J., Klein, P., Ramaswamy, B., Brufsky, A., Stella, P. J., Burnette, B., Telli, M., Makower, D. F., Cheema, P., Truica, C. I., Wolff, A. C., Soori, G. S., Haley, B., Wassenaar, T. R., Goldstein, L. J., Miller, K. D. & Sparano, J. A., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1556-1563 8 p.

Research output: Contribution to journalArticle

Reply to C. Murray et al and v. Martin et al

Wolff, A. C., Hammond, M. E. H., Allison, K. H., Harvey, B. E., McShane, L. M. & Dowsett, M., Dec 10 2018, In : Journal of Clinical Oncology. 36, 35, p. 3524 1 p.

Research output: Contribution to journalLetter

Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update

Denduluri, N., Chavez-MacGregor, M., Telli, M. L., Eisen, A., Graff, S. L., Hassett, M. J., Holloway, J. N., Hurria, A., King, T. A., Lyman, G. H., Partridge, A. H., Somerfield, M. R., Trudeau, M. E., Wolff, A. C. & Giordano, S. H., Aug 10 2018, In : Journal of Clinical Oncology. 36, 23, p. 2433-2443 11 p.

Research output: Contribution to journalArticle

2017

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients

Rosenstock, A. S., Niu, J., Giordano, S. H., Zhao, H., Wolff, A. C. & Chavez-Macgregor, M., Jan 1 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle